full-service outsourcing

R&D

Biotech and pharma companies increasingly require additional agility, flexibility, and operational efficiency in their clinical research operations.

News

AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.